Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vivlodex in Osteoarthritis Pain
NCT01787188Phase 3Completed
- Sponsor
- Iroko Pharmaceuticals, LLC
- Start
- Feb 2013
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of meloxicam in osteoarthritis (OA), sponsored by Iroko Pharmaceuticals, LLC. Started Feb 2013; status: completed.
02
Drugs
meloxicam
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01787188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01787188.